---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-21-007757"
form_type: "8-K"
ticker: "VTGN"
cik: "0001411685"
company_name: "Vistagen Therapeutics, Inc."
filed_at: "2021-07-08T23:59:59+00:00"
generated_at: "2026-06-30T06:33:53.861974+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# VistaGen appoints healthcare attorney Mary L. Rotunno to board

## Summary
- Mary L. Rotunno, J.D., appointed to VistaGen's Board of Directors effective July 6, 2021.
- Rotunno currently serves as General Counsel of El Camino Health, a $1B revenue health system.
- She is considered an independent director under Nasdaq listing rules.
- Company entered into a standard indemnification agreement with Rotunno.
- Rotunno brings over 30 years of healthcare legal and nursing experience.

## SEC filing metadata
- accession: 0001654954-21-007757
- form_type: 8-K
- ticker: VTGN
- cik: 0001411685
- company_name: Vistagen Therapeutics, Inc.
- filed_at: 2021-07-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1411685/000165495421007757/0001654954-21-007757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1411685/000165495421007757/vtgn8k_07062021.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-21-007757
- JSON: https://secwatch.observer/filing/0001654954-21-007757.json
- Plain text: https://secwatch.observer/filing/0001654954-21-007757.txt

## Key facts
- Executive change
  Mary L. Rotunno was appointed as Director at Vistagen Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 6, 2021, Mary L. Rotunno J.D. was appointed to serve on the Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1411685/000165495421007757/0001654954-21-007757-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.